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The mammalian Sir2 ortholog Sirt1 plays an impor-
tant role in metabolic regulation. However, the role
of Sirt1 in the regulation of aging and longevity is still
controversial. Here we demonstrate that brain-
specific Sirt1-overexpressing (BRASTO) transgenic
mice show significant life span extension in both
males and females, and aged BRASTO mice exhibit
phenotypes consistent with a delay in aging. These
phenotypes are mediated by enhanced neural activ-
ity specifically in the dorsomedial and lateral hypo-
thalamic nuclei (DMH and LH, respectively), through
increased orexin type 2 receptor (Ox2r) expression.
We identified Nk2 homeobox 1 (Nkx2-1) as a partner
of Sirt1 that upregulates Ox2r transcription and
colocalizes with Sirt1 in the DMH and LH. DMH/LH-
specific knockdown of Sirt1, Nkx2-1, or Ox2r and
DMH-specific Sirt1 overexpression further support
the role of Sirt1/Nkx2-1/Ox2r-mediated signaling for
longevity-associated phenotypes. Our findings indi-
cate the importance of DMH/LH-predominant Sirt1
activity in the regulation of aging and longevity in
mammals.
INTRODUCTION
Over the past decade, a number of evolutionarily conserved
regulators and signaling pathways have been identified for the
control of aging and longevity. These regulators and signaling
pathways, including insulin/insulin-like growth factor 1 (IGF-1)
signaling (IIS) (Kenyon, 2010), mammalian target of rapamycin
(mTOR) signaling (Zoncu et al., 2011), and NAD-dependent sir-
tuins (Haigis and Sinclair, 2010), provide excellent probes to
dissect complex hierarchical mechanisms that affect the aging
process and longevity in each model organism. Recent studies416 Cell Metabolism 18, 416–430, September 3, 2013 ª2013 Elseviein worms and flies have also suggested that systemic interplay
between multiple tissues regulates aging and longevity (Demon-
tis and Perrimon, 2010; Durieux et al., 2011). In mammals,
however, the complexity of tissue interplay is multiplied, and a
blueprint for a systemic network regulating aging and longevity
still remains elusive. Most recently, it has been shown that hypo-
thalamic NF-kB signaling plays a critical role in the regulation of
systemic aging via immune-neuroendocrine integration in mice,
implicating the importance of the hypothalamus in systemic
aging/longevity control in mammals (Zhang et al., 2013). Indeed,
the hypothalamus communicates with multiple peripheral tis-
sues via hormonal and neural networks and coordinates meta-
bolic and behavioral responses to nutritional and environmental
stimuli. For instance, neurons producing growth hormone (GH)-
releasing hormone and somatostatin that stimulate and inhibit
GH release in the anterior pituitary gland, respectively, are local-
ized in the hypothalamus. The growth hormone (GH)/IGF-1 axis,
which regulates somatic growth, metabolism, and tissue repair,
has been well established to control aging and longevity in mam-
mals (Bartke, 2011). Therefore, this particular tissue in the brain
appears to function as a critical juncture for the coordination of
metabolic signaling and aging/longevity control in mammals.
Sir2 (silent information regulator 2) family proteins, now called
‘‘sirtuins,’’ have been demonstrated to coordinate metabolic re-
sponses to changes in nutritional availability and maintain phys-
iological homeostasis in mammals (Haigis and Sinclair, 2010).
These functions of sirtuins are ascribed to their unique NAD-
dependent enzymatic activities (Feldman et al., 2012), placing
sirtuins at the perfect position to integrate energy metabolism
information into many other biological regulations. In particular,
the mammalian Sir2 ortholog Sirt1 plays a critical role for the
regulation of metabolic responses in multiple tissues, including
the liver, skeletal muscle, adipose tissue, and brain, through its
deacetylase activity (Haigis and Sinclair, 2010). Sirt1 also plays
a role in the regulation of phenotypes induced by diet restriction
(DR), a diet regimen that delays aging and extends life span in a
wide variety of organisms (Haigis and Sinclair, 2010). Whereas
the whole-body and brain-specific Sirt1 knockout mice fail to
respond to DR (Chen et al., 2005; Cohen et al., 2009; Kumer Inc.
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mice display phenotypes similar to DR mice (Bordone et al.,
2007) or preventive effects on metabolic complications caused
by high-fat diet and aging (Banks et al., 2008; Pfluger et al.,
2008). However, whole-body Sirt1-overexpressing mice fail to
show life span extension (Herranz et al., 2010). Additionally,
the importance of Sir2 orthologs for aging/longevity control in
worms and flies has recently been called into question (Burnett
et al., 2011). Therefore, whether Sirt1 plays an important role in
the regulation of aging and longevity in mammals has been a
big controversy in the field of aging research.
We have previously demonstrated that hypothalamic Sirt1
functions as a key mediator of the neurobehavioral adaptive
response to DR (Satoh et al., 2010). DR significantly increases
Sirt1 protein levels and induces neural activation in the dorsome-
dial and lateral hypothalamic nuclei (DMH and LH, respectively).
Interestingly, brain-specific Sirt1-overexpressing (BRASTO)
transgenic mice exhibit significantly enhanced neural activity
specifically in the DMH and LH and augmented neurobehavioral
responses to diet-restricting conditions, whereas these re-
sponses are abrogated in Sirt1-deficient mice (Satoh et al.,
2010). Given that DR significantly delays the aging process
and extends life span in a variety of animal species, we hypoth-
esized that BRASTO mice might show significant beneficial
effects on the aging process and even longevity. Here we
show that BRASTO mice exhibit a significant delay in the aging
process and extension of life span in both males and females.
Sirt1-dependent neural activation in the DMH and LH protects
against age-related declines in skeletal muscle mitochondrial
function, physical activity, body temperature, oxygen consump-
tion, and quality of sleep. Sirt1 and its partner Nk2 homeobox 1
(Nkx2-1) regulate these physiological functions through the up-
regulation of orexin type 2 receptor (Ox2r) expression in the
DMH and LH, and their colocalization identifies a specific subset
of neurons in these hypothalamic regions. Our findings provide
critical insight into the importance of hypothalamic Sirt1 and its
role in the systemic regulation of tissue communication, aging,
and longevity in mammals.
RESULTS
BRASTOMice Show Significant Life Span Extension and
Delay in the Aging Process Compared to Control Mice
Our previous study on the role of hypothalamic Sirt1 in the cen-
tral adaptive response to low energy intake such as DRprovoked
a hypothesis that hypothalamic Sirt1might play an important role
in the regulation of the aging process and possibly longevity
under an ad libitum regular chow-fed condition in mammals
(Satoh et al., 2010). To address this hypothesis, we examined
the life span and the age-associated physiological changes in
male and female mice overexpressing Sirt1 in the brain
(BRASTO, line 10). This particular line has a Sirt1 expression pro-
file in the hypothalamus very similar to that induced by DR in
wild-type mice, namely the DMH/LH-predominant increase in
Sirt1 expression (Satoh et al., 2010). To avoid any unexpected
genetic effects on aging and longevity in this line, we conducted
whole-genome sequencing and confirmed that there were no
hidden mutations or deletions in this transgenic line 10 (data
not shown). This whole-genome analysis also allowed us to iden-Cell Metify the integration site of the transgene (see Figure S1A online).
Approximately 14 tandem copies of the transgene were inte-
grated into a long intron of the Ccdc7 gene on chromosome 8.
This gene, whose function is unknown, had no detectable
expression in most peripheral tissues and the brain, including
the soleus muscle, cortex, and hypothalamus, in both males
and females (Wang et al., 2009; data not shown). The only excep-
tion was testis in males, and one of the splicing variants showed
a decrease in its expression only in testis from BRASTO males
compared to controls (Figure S1B). No microRNAs were pre-
dicted at or around this integration site. Therefore, based on
the whole-genome and expression analyses, there is no evi-
dence for any additional genetic changes that systemically affect
both males and females in this transgenic line.
Importantly, when fed regular chow ad libitum, both BRASTO
females and BRASTO males showed significant life span exten-
sion. BRASTO females showed 16% extension for median life
span (control 799 days versus BRASTO 930 days, log rank test,
c2 = 12.2, df = 1, p < 0.001) and statistically significant extension
for maximal life span (10% oldest control 1,015 ± 15 days versus
BRASTO 1,076 ± 10 days, t test, p < 0.05; 20% oldest control
973 ± 15 days versus BRASTO 1,056 ± 10 days, t test, p <
0.001) (Figure 1A and Figure S1C). BRASTO males showed
9% extension in median life span (control 849 days versus
BRASTO 926 days, log rank test, c2 = 5.9, df = 1, p = 0.015)
and a trend of maximal life span extension (10% oldest control
1,066 ± 15 days versus BRASTO 1,105 ± 9 days, not significant;
20% oldest control 1,034 ± 15 days versus BRASTO 1,084 ±
9 days, t test, p < 0.05). Combined sex results showed 11%
extension for median life span (control 835 days versus BRASTO
926 days; log rank test, c2 = 14.8, df = 1, p < 0.001) and statisti-
cally significant maximal life span extension (10% oldest control
1,049 ± 13 days versus BRASTO 1,092 ± 8 days, t test, p < 0.001;
20% oldest 1,003 ± 13 days versus BRASTO 1,070 ± 8 days,
t test, p < 0.001).
We also assessed age-associated mortality and cancer-
dependent death incidence in BRASTO mice. Both BRASTO
females and males, as well as combined results, showed signif-
icant delays in age-associated mortality, whereas the slopes of
age-associated mortality change, which mathematically defines
the rate of aging (de Magalha˜es et al., 2005), did not differ
between BRASTO and control mice (Figure 1B). We also
observed a similar delay in cancer-dependent death incidence,
whereas the slopes of accumulating death incidents and the
spectrum of cancers did not differ between BRASTO and control
mice (Figures 1C and 1D). These results suggest that the onset
of age-associated physiological decline is delayed without
affecting the rate of aging in BRASTO mice.
Aged BRASTO Mice Display Significant Enhancement in
Physical Activity, Body Temperature, Oxygen
Consumption, and Quality of Sleep Compared to
Age-Matched Control Mice
As previously reported at 5 months of age (Satoh et al., 2010),
BRASTO and control mice at 20 months of age exhibited no sig-
nificant differences in body weight; fed and fasted blood
glucose, insulin, and lipid levels; and glucose and insulin
tolerance (Figures S2A–S2H). Nonetheless, BRASTO mice at
20 months of age showed significantly higher physical activitytabolism 18, 416–430, September 3, 2013 ª2013 Elsevier Inc. 417
Figure 1. BRASTO Mice Show the Extension of Both Median and Maximum Life Span and Delay the Age-Associated Mortality Rate and the
Incidence of Cancer-Dependent Death
(A) Kaplan-Meier curves of BRASTO (Tg) and wild-type control (WT) mice in females (top left), males (top right), and combined sex (bottom left). p values shown
were calculated by log rank test.
(B) Changes in age-associated mortality rate by plotting linear hazard rate in females, males, and combined sex. p values for the differences of fitted slopes (not
significant) and y axis intercepts (shown in each panel) were calculated by ANCOVA between BRASTO and wild-type control mice.
(C and D) Accumulating incidents of cancer-dependent deaths (C) and identified causes of death (D) in aged BRASTO andwild-type control mice. p value (top) for
the difference of the two genotypes was calculated by log rank test. p values for the differences of fitted slopes (not significant) and y axis intercepts (bottom) were
calculated by ANCOVA. See also Figure S1.
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Figure 2. Aged BRASTO Mice Display Higher Physical Activity, Body Temperature, and Oxygen Consumption, and Better Quality of Sleep
Compared to Wild-Type Control Mice
(A) Wheel-running activity of BRASTO (Tg) and wild-type control (WT) mice at 20 months (left) and 4 months (right) of age, respectively. Activity counts per minute
at each time point are shown as mean values ± SE (***p < 0.001 by Wilcoxon matched-pairs singled-ranks test, n = 10–12 mice for each genotype).
(B and C) Rectal body temperature (B) and oxygen consumption (VO2) (C) at 20 months of age. Rectal body temperature and VO2 at each time point are shown as
mean values ± SE (**p < 0.01 by Student’s t test [B]; *p < 0.05 by Wilcoxon matched-pairs singled-ranks test [C, 10 p.m. to 5 a.m.], n = 10–12 mice for each
genotype).
(D and E) Levels of delta power in NREM sleep (D) and wake (E) at 20 months of age. Levels of delta power at each time point are shown as mean values ± SE
(***p < 0.001 by Wilcoxon matched-pairs singled-ranks test, n = 5–6 mice for each genotype). Shaded area represents the dark time. See also Figure S2.
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whereas they showed no difference at 4months of age (Figure 2A
and Figure S2I). Twenty-month-old BRASTOmice also exhibited
higher rectal body temperature and oxygen consumption, and a
trend of increased energy expenditure during the dark time
compared to control mice, consistent with increased nocturnal
food intake in aged BRASTO mice (Figures 2B and 2C and Fig-
ures S2J and S2K). Additionally, we examined their sleep-wake
patterns because of the connection between Sirt1 and orexin
signaling (Panossian et al., 2011; Ramadori et al., 2011; SatohCell Meet al., 2010). It has been reported that the delta power in non-
REM (NREM) sleep, a parameter representing the quality or
depth of sleep (Krueger et al., 2008), declines over age in rodents
and humans (Hasan et al., 2010; Landolt et al., 1996). Intrigu-
ingly, aged BRASTO mice showed higher delta power in
NREM sleep compared to control mice, whereas they showed
no difference in the delta power in wake (Figures 2D and 2E),
suggesting that aged BRASTOmice have better or deeper sleep.
Four-month-old BRASTO and control mice showed no differ-
ence in the delta power in either NREM sleep or wake (datatabolism 18, 416–430, September 3, 2013 ª2013 Elsevier Inc. 419
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through 24 hr did not differ between young and aged BRASTO
and control mice (Figure S2L and data not shown). Taken
together, these findings support the notion that the onset of
age-associated physiological decline is significantly delayed in
aged BRASTO mice compared to age-matched control mice.
Aged BRASTO Mice Show More Youthful Mitochondrial
Morphology and Function in Skeletal Muscle
To assess which tissue is possibly involved in delaying the aging
process in BRASTO mice, we initially examined the expression
profiles of key functional genes in white adipose tissue (WAT),
brown adipose tissue (BAT), and liver. Consistent with the lack
of obvious metabolic differences, we did not detect any signifi-
cant changes in gene expression profiles in WAT, BAT, and liver,
except for a decrease in glucose-6-phosphatase (G6pase) only
during the dark time in the liver (Figure S3A). We also found
that BAT activity, which was assessed by the diurnal expression
patterns of uncoupling protein 1 (Ucp1) and peroxisome prolifer-
ator-activated receptor g coactivator-1 a (Pgc-1a), was higher
during the light time and lower during the dark time (Figure S3B),
suggesting that BAT cannot be responsible for the dark time-
specific enhancement in physical activity, body temperature,
and oxygen consumption in aged BRASTO mice. Because skel-
etal muscle is another important tissue for thermogenesis in
rodents, we next conducted morphometric analysis of skeletal
muscle by electron microscopy between BRASTO and control
mice at 20 months of age. In aged wild-type skeletal muscle,
the organization of sarcomeres was often disturbed, and sur-
rounding mitochondria were frequently absent, fused, or swollen
(Figure 3A, left picture, white arrows). Strikingly, in aged
BRASTO skeletal muscle, their sarcomeres were still well orga-
nized, and their mitochondria exhibited much less abnormality
(Figure 3A, right picture). Consistent with these observations,
the number of mitochondria was significantly higher, and their
size was significantly smaller in aged BRASTO skeletal muscle
compared to age-matched controls (Figure 3B). We also exam-
ined the expression of genes related to mitochondrial functions,
such as Pgc-1a, isocitrate dehydrogenase 3a (Idh3a), and cyto-
chrome b (Cytb). Pgc-1a expression tended to show a diurnal
oscillation, showing lower expression during the light time
(3 p.m.) and higher expression during the dark time (9 p.m.) in
skeletal muscle. Interestingly, skeletal muscle of aged BRASTO
mice showed much higher Pgc-1a expression during the dark
time compared to control Pgc-1a expression during both light
and dark times and BRASTO Pgc-1a expression during the light
time (Figure 3C, left panel). The expression of Idh3a and Cytb in
aged BRASTO skeletal muscle was also the highest during the
dark time (Figure 3C, middle and right panels), although the dif-
ference for Cytb did not reach statistical significance.
In BRASTO skeletal muscle, there is no overexpression of Sirt1
(Satoh et al., 2010). Why did the skeletal muscle have more
youthful morphology and function in aged BRASTO mice? We
initially suspected the involvement of hormones that are known
to stimulate skeletal muscle function and examined the levels
of corticosterone, thyroid hormones T3 and T4, and IGF-1 in
the blood during the light and dark times in aged BRASTO and
control mice. There were no differences in any of these hor-
mones between BRASTO and control mice (Figure S3C), sug-420 Cell Metabolism 18, 416–430, September 3, 2013 ª2013 Elseviegesting that the observed phenotypes in aged BRASTO skeletal
muscle were probably not due to hormonal changes. It has been
well known that skeletal muscle receives stimulation through the
sympathetic nervous system, leading to increases in the expres-
sion of b2 adrenergic receptor (Adrb2), a predominant subtype
expressed in skeletal muscle, and cAMP levels (Lynch and Ryall,
2008). Consistent with this notion, we confirmed that Adrb2
expression increased in skeletal muscle during the dark time in
4-month-old BRASTO and control mice (Figure 3D, left panel).
The diurnal changes in Adrb2 expression were abolished in
aged wild-type skeletal muscle, whereas these changes were
nicely maintained in aged BRASTO skeletal muscle (Figure 3D,
right panel). cAMP levels also showed a significant increase dur-
ing the dark time in aged BRASTO skeletal muscle (Figure S3D),
indicating that skeletal muscle is indeed stimulated through the
sympathetic nervous system in aged BRASTO mice.
Neural Activity and Ox2r Expression Are Significantly
Enhanced in the DMH and LH during the Dark Time in
Aged BRASTO Mice
The hypothalamus, particularly the DMH, has been known to
regulate autonomic nervous activity. Therefore, we examined
neural activity in different hypothalamic nuclei during the dark
time by quantitating cFos expression levels. Interestingly, in
the aged BRASTO hypothalamus, the DMH and LH, but not
the arcuate and ventromedial hypothalamic nuclei (Arc and
VMH, respectively), showed significant enhancement of cFos
expression during the dark time compared to age-matched con-
trols (Figure 3E). Because Ox2r is one of the major Sirt1 target
genes in the hypothalamus (Satoh et al., 2010), we also exam-
ined the Ox2r expression levels during the dark time in aged
BRASTO and control hypothalami. Consistent with cFos expres-
sion, Ox2r expression was significantly enhanced in the DMH
and LH, but not in the Arc and VMH, in aged BRASTO mice (Fig-
ure 3F). Indeed, Ox2r expression showed a diurnal oscillation
with higher and lower expression levels during the dark and light
times, respectively (Figure S3E), consistent with the diurnal
patterns of the observed BRASTO phenotypes. We also exam-
ined the expression levels of proopiomelanocortin (Pomc), neu-
ropeptide Y (Npy), and agouti-related protein (Agrp) in the Arc,
melanocortin-4 receptor (Mc4r) in the VMH, and orexin and
melanin-concentrating hormone (Mch) in the LH. These gene
expression levels did not differ between aged BRASTO and con-
trol mice (Figure S3F). Therefore, our findings suggest that neural
activity in the DMH and LH is specifically enhanced during the
dark time in aged BRASTOmice, possibly through the upregula-
tion of Ox2r expression in these hypothalamic regions, resulting
in skeletal muscle stimulation through the sympathetic nervous
system.
Sirt1 Enhances Ox2r Promoter Activity through the
Deacetylation of Nkx2-1
Because our findings indicate that the upregulation of Ox2r by
Sirt1 in the DMH and LH might be an important mechanism for
the observed phenotypes in BRASTO mice, we decided to
examine how Sirt1 regulates Ox2r expression. In our previous
study, we demonstrated that Sirt1 enhances the activity of the
Ox2r promoter in a dose-dependent manner in cultured cells
(Satoh et al., 2010). We narrowed down the Sirt1-responsiver Inc.
Figure 3. Aged BRASTO Mice Show More Youthful Mitochondrial Morphology and Function in Skeletal Muscle and Enhanced Neural
Activation Specifically in the DMH and LH
(A and B) Morphometric analysis of the soleus muscle from aged BRASTO (Tg) and wild-type control (WT) mice. Representative electron microscope images are
shown (A). The number (top) and the size (bottom) of mitochondria were measured (B), and results are shown as mean values ± SE (*p < 0.05, ***p < 0.001, n = 3
mice for each genotype, 10–15 sections per mouse).
(C and D) mRNA expression levels of genes related to skeletal muscle mitochondrial function (Pgc1a, Idh3a, and Cytb, C) and stimulation by the sympathetic
nervous system (Adrb2, D) in the soleus muscle of young (D, left panel) and aged (C and D, right panel) BRASTO and wild-type control mice at 3 p.m. and 9 p.m.
Each mRNA expression level was normalized to that of WT at 3 p.m. Results are shown as mean values ± SE (*p < 0.05, **p < 0.01, ***p < 0.001, n = 4–6 mice for
each genotype).
(E and F) mRNA expression levels of cFos (E) andOx2r (F) in the Arc, VMH, DMH, and LH of aged BRASTO andwild-type control mice at 9 p.m. Results are shown
asmean values ± SE (*p < 0.05, **p < 0.01, n = 3–4mice for each genotype). mRNA expression levels in each hypothalamic nucleuswere normalized to those in the
WT Arc. See also Figure S3.
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Figure 4. Sirt1 Enhances Ox2r Promoter Activity by Interacting with and Deacetylating a Homeodomain Transcription Factor Nkx2-1
(A–C) Luciferase activities driven by the 1 kb and truncated Ox2r promoter fragments (A and B, Ox2r-Luc) or the 260 bp Ox2r promoter or mutant carrying
mutations in two Nk2 family binding sites (C, Ox2r-112/251mut) in HEK293 cells cotransfected with a Sirt1 minigene or mutant Sirt1 (H355A) (A and B) and/or
Nkx2-1 (pCMV-Nkx2-1) (B and C). Luciferase activities in cells cotransfected with a backbone vector were normalized to 100%. Results are shown as mean
values ± SE (control versus treatment, *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Tukey-Kramer post hoc test [A–C]; pCMV-Nkx2-1 alone versus
pCMV-Nkx2-1 with Sirt1 minigene, {p < 0.05, {{p < 0.01, {{{p < 0.001 by Student’s t test [B and C]; pCMV-Nkx2-1 with Sirt1 minigene versus pCMV-Nkx2-1
with H355A [B] or Ox2r-260bp versus Ox2r-112/251mut [C], xp < 0.05, xxp < 0.01 by Student’s t test, n = 3–9).
(D) Chromatin immunoprecipitation for Nkx2-1 in the hypothalamus. Primer set 1 is designed for an unrelated genomic region. Locations of primer sets 2–4 are
shown in the upper panel. Nk2 family binding sites are located at 112 and 251 positions with respect to the transcription start site in the Ox2r promoter.
(E–G) Coimmunoprecipitation showing the interaction of Sirt1 and Nkx2-1 overexpressed in HEK293 cells (E and F) and in the hypothalamic extracts (G).
(H) Deacetylation of Nkx2-1 by Sirt1 in HEK293 cells.
(legend continued on next page)
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Within this 260 bp promoter region, there are two binding sites
of the cAMP response element binding protein (CREB) and two
binding sites of the Nk2 family of homeobox transcription factors
(Figure S4). We found that the Ox2r promoter did not respond to
CREB alone or CREB plus Sirt1 (data not shown). Among Nk2
family transcription factors, Nkx2-1 is localized in the hypothala-
mus in rodents (Kim et al., 2006; Mastronardi et al., 2006). An un-
biased proteomic screen also suggests that Nkx2-1 could be a
potential Sirt1-interacting partner (Armour et al., 2013). There-
fore, we examined whether Sirt1 and Nkx2-1 cooperate to
activate the Ox2r promoter. Sirt1 or Nkx2-1 alone was able to
activate the Ox2r promoter, whereas the combination of Sirt1
and Nkx2-1 further enhanced the promoter activity (Figure 4B).
An enzymatically deficient Sirt1 mutant H355A failed to coop-
erate with Nkx2-1, suggesting that Sirt1 enzymatic activity is
necessary for the upregulation of theOx2r promoter activity (Fig-
ure 4B). Additionally, mutating both proximal Nk2 family binding
sites abolished the response to Nkx2-1 or Sirt1 alone and ex-
hibited significant reduction in the Sirt1/Nkx2-1-dependent
enhancement of the promoter activity (Figure 4C). Furthermore,
hypothalamic chromatin immunoprecipitation using an Nkx2-1-
specific antibody showed that Nkx2-1 localized in the proximal
promoter regions containing or close to two Nk2 family binding
sites (Figure 4D), the regions where Sirt1 also localizes (Satoh
et al., 2010). These results suggest that Sirt1 and Nkx2-1 coloc-
alize on Nk2 family binding sites in the 260 bpOx2r proximal pro-
moter region and cooperate to upregulate the promoter activity.
We next examined whether Sirt1 and Nkx2-1 physically
interact. When overexpressing both proteins in cultured cells,
we detected the reciprocal interaction between Sirt1 and
Nkx2-1 (Figures 4E and 4F). We also detected the interaction
between endogenous Sirt1 and Nkx2-1 in hypothalamic extracts
(Figure 4G). It has been reported that K161 and K182 of the
Nkx2-1 protein are acetylated in cultured cells (Yang et al.,
2004). Because Sirt1 tends to interact with its deacetylation sub-
strates, we examined whether Sirt1 deacetylates Nkx2-1. We
found that increasing Sirt1 protein expression decreased the
acetylation of Nkx2-1 in a dose-dependent manner (Figure 4H).
We then introduced acetylation-mimicking K-to-Q mutations
to K161, K182, and K215, all of which are located in the homeo-
domain of Nkx2-1 (Figure 4I). K161Q and K182Q mutants
completely abolished the cooperativity with Sirt1, whereas the
K215Qmutant was still able to upregulateOx2r promoter activity
with Sirt1 (Figure 4I), indicating that Sirt1 enhances the transcrip-
tional activity of Nkx2-1 through the deacetylation of K161 and
K182 in its homeodomain and upregulates Ox2r expression.
To confirm that Nkx2-1 is indeed involved in the regulation of
Ox2r gene expression, we knocked down Nkx2-1 in primary(I) Luciferase activity of Ox2r-Luc in HEK293 cells cotransfected with a Sirt1 minig
(K161Q, K182Q, or K215Q). Results are shown as mean values ± SE (control versu
Kramer post hoc test; pCMV-Nkx2-1 alone versus pCMV-Nkx2-1 with Sirt1 m
Sirt1 minigene, {p < 0.05, {{{p < 0.001 by Student’s t test, n = 6). These three ly
structure of Nkx2-1. Acetylated lysine residues are shown in red.
(J) mRNA expression levels of Nkx2-1 and Ox2r after knockdown of Nkx2-1 in prim
in control firefly luciferase (fLuc) knockdown cells for each gene. Results are sh
t test, n = 3).
(K) Acetylation levels of Nkx2-1 in hypothalamic extracts at 3 p.m. (light time) an
Cell Mehypothalamic neurons. The expression of Ox2r decreased by
73% when Nkx2-1 expression was knocked down by 94% (Fig-
ure 4J), indicating that Nkx2-1 is important for the regulation of
Ox2r expression in hypothalamic neurons. We also found that
Nkx2-1 showed less acetylation at 9 p.m. (dark time) compared
to 3 p.m. (light time) (Figure 4K), consistent with the higher
expression of Ox2r during the dark time in the hypothalamus
(Figure S3E). Taken together, these results suggest that Sirt1
and Nkx2-1 cooperate to activate Ox2r expression in the hypo-
thalamus during the dark time.
The Sirt1/Nkx2-1/Ox2r-Mediated Pathway Is Necessary
for the Maintenance of Physical Activity, Body
Temperature, Skeletal Muscle Mitochondrial Function,
and Quality of Sleep
Consistent with the cooperativity between Sirt1 and Nkx2-1, we
found that Sirt1 and Nkx2-1 colocalized in the DMH and LH (Fig-
ure 5A and Figure S5A). Their colocalization was more extensive
in the DMH, particularly in the compact region of the DMH,
where 90% of Sirt1-positive cells were Nkx2-1 positive (Fig-
ure 5A). In the LH,60%of Sirt1-positive cells were Nkx2-1 pos-
itive (Figure S5A). These Sirt1/Nkx2-1 double-positive cells in the
DMH were positive for NeuN, a marker for neurons, but nega-
tive for either vesicular glutamate transporter 2 or glutamate
decarboxylase 1, markers for glutamatergic and GABAergic
neurons, respectively (data not shown). We are currently trying
to determine the identity of these Sirt1/Nkx2-1 double-positive
neurons.
Because of this significant colocalization between Sirt1 and
Nkx2-1 in the DMH and LH, we asked whether Sirt1, its partner
Nkx2-1, and their target gene product Ox2r are necessary for
any physiological phenotypes that were significantly enhanced
in aged BRASTOmice. Because no Cre driver mice are available
for targeting the DMH and LH, we employed stereotactic injec-
tion of shRNA lentiviruses against each gene specifically into
the DMH and LH. We first conducted this experiment in 4- to
5-month-old wild-type mice. The specificity of the injection into
the DMH and LH was always confirmed by the expression of
GFP (Figure S5B), and the knockdown efficiency was assessed
by analyzing each gene expression in each hypothalamic
nucleus. Sirt1, Nkx2-1, and Ox2r expression was reduced by
50%–70% specifically in the DMH and LH, but not in other hypo-
thalamic nuclei (Figure S5C). Remarkably, physical activity dur-
ing the dark time was significantly reduced by knocking down
Sirt1, Nkx2-1, or Ox2r in the DMH and LH (Figure 5B and Fig-
ure S5D). Interestingly, Sirt1 knockdown exhibited the most
extensive reduction in physical activity, whereas Nkx2-1 and
Ox2r knockdown showed less and almost indistinguishable re-
ductions. We also observed similar effects in rectal bodyene and/or pCMV-Nkx2-1 or Nkx2-1mutants carrying different point mutations
s treatment, *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Tukey-
inigene or pCMV-Nkx2-1 [K215Q] alone versus pCMV-Nkx2-1 [K215Q] with
sines lie within the homeodomain of Nkx2-1 protein as shown in the schematic
ary hypothalamic neurons. mRNA expression levels were normalized to those
own as mean value ± SE (control versus treatment, ***p < 0.001 by Student’s
d 9 p.m. (dark time). See also Figure S4.
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Figure 5. Sirt1, Nkx2-1, and Their Target Gene Product Ox2r in the DMH and LH Are Required to Maintain Physical Activity, Body Temper-
ature, Skeletal Muscle Gene Expression, and Quality of Sleep during the Dark Time
(A) Immunofluorescence of Sirt1 (green), Nkx2-1 (red), andmerged image (right) in the DMH.White boxes show areas that are magnified at the lower right corners
of each panel.
(legend continued on next page)
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Hypothalamic Sirt1 Controls Aging and Longevitytemperature during the dark time (Figure 5C). Furthermore, gene
expression representing skeletal muscle mitochondrial function
(Pgc-1a, Idh3a, and Cytb) and stimulation by the sympathetic
nervous system (Adrb2) was also significantly reduced during
the dark time (Figure 5D). The delta power in NREM sleep was
also significantly affected by knocking down Sirt1 and Nkx2-1
(Figure 5E). These results demonstrate that the molecular
pathway mediated by Sirt1, Nkx2-1, and Ox2r in the DMH and
LH is necessary for those physiological functions during the
dark time.
To further confirm the importance of Sirt1/Ox2r signaling in the
DMH and LH for age-associated BRASTO phenotypes, we next
knocked down Sirt1 and Ox2r specifically in the DMH and LH of
20-month-old BRASTO and control mice (Figures 5F and 5G and
Figures S5E–S5H). Aged control mice showed significantly less
physical activity and body temperature during the dark time
compared to those in young mice, and knockdown of Sirt1 or
Ox2r in the DMH and LH did not show further reductions.
Contrarily, in aged BRASTO mice, the DMH/LH-specific knock-
down of Sirt1 or Ox2r completely abolished the enhancement of
physical activity and body temperature that the aged BRASTO
mice with control knockdown still displayed. Additionally,
DMH-specific overexpression of Sirt1 in 17- to 18-month-old
wild-type B6 mice dramatically enhanced their physical activity
and body temperature during the dark time to the levels compa-
rable to those in 4- to 5-month-old B6 mice (Figures 5H and 5I).
These results clearly demonstrate that the enhanced Sirt1/Ox2r
signaling in the DMH and LH is critical to counteract age-associ-
ated physiological decline.
Activation of the DMH and LH and Resultant
Physiological Changes Are Causally Associated with
Life Span Extension in Mice
Our previous study demonstrates that Sirt1 in the DMH and LH
is important for the central adaptive response to DR, a dietary
regimen well known to affect aging and longevity in mammals.
Results from the DMH/LH-specific stereotactic experiments
further provide strong support for the causal role of Sirt1/
Ox2r signaling in the DMH and LH for the significant delay in
physiological phenotypes during aging. Nonetheless, in mam-
mals, the technical difficulty of repeating life span experiments
multiple times makes it very difficult to prove the strict causality
of an identified mechanism for life span extension. In our case,
we happened to have another line of BRASTO mice, line 1,
which has much higher Sirt1 protein expression throughout
the brain (Satoh et al., 2010). Indeed, Sirt1 expression was
much higher and similar through all hypothalamic nuclei in(B and C) Wheel-running activity (B) and rectal body temperature (C) in DMH/LH
luciferase (fLuc) knockdown mice. Results at each time point are shown as mea
singled-ranks test [B] or Student’s t test [C], n = 6 mice for each group).
(D) mRNA expression levels of skeletal muscle genes Pgc1a, Idh3a, Cytb, and Ad
mean values ± SE (*p < 0.05 by one-way ANOVA with Tukey-Kramer post hoc te
(E) Levels of delta power in NREM sleep. Levels of delta power at each time po
singled-ranks test, n = 3–4 mice for each group).
(F–I) Wheel-running activity (F and H) and rectal body temperature (G and I) in DMH
(Tg) or wild-type control (WT) mice (F and G) or DMH-specific Sirt1 overexpression
are shown asmean values ± SE (Tg-fLuc versusWT-fLuc, ##p < 0.01; Tg-fLuc vers
by Wilcoxon matched-pairs singled-ranks test; *p < 0.05 by one-way ANOVA with
group). Shaded area represents the dark time. See also Figure S5.
Cell Meline 1 compared to line 10, whereas Sirt1 expression levels in
the DMH and LH were significantly higher compared to those
in the Arc and VMH in line 10 (Figure 6A). Interestingly, in
aged line 1 BRASTO mice, we found that there was no
cFos activation in the DMH and LH during the dark time
(Figure 6B). Instead, there was a significant enhancement of
cFos activation only in the Arc in aged line 1 BRASTO mice
(Figure 6B). Furthermore, the expression levels of Pomc, but
not other neuropeptide genes, were significantly enhanced in
the Arc in line 1 (Figure S6A). Therefore, in light of the results
from line 10, this particular set of two BRASTO transgenic lines
provided an interesting opportunity to test the tight association
between neural activation in the DMH and LH and life span
extension.
We conducted whole-genome sequencing for line 1 and
confirmed that there were no hidden mutations or deletions,
except for one synonymous homozygous single nucleotide poly-
morphism (data not shown). Approximately 16 tandem copies of
the transgenewere integrated into the region on chromosome 15
that is 0.5–1 Mbp away from the closest flanking genes (Fig-
ure S6B). No microRNAs were predicted around the integration
site. Surprisingly, this line of BRASTO mice showed the life
span indistinguishable from that of wild-type control mice (Fig-
ure 6C and Figure S6C). They also showed a cancer spectrum
indistinguishable from that of wild-type control mice (Figure 6D).
Furthermore, aged BRASTO mice in line 1 exhibited no differ-
ence in metabolic parameters (Figures S6D–S6L) and no
enhancement of the physiological phenotypes that were signifi-
cantly enhanced in line 10, including physical activity, rectal
body temperature, and gene expression representing skeletal
muscle function (Figures 6E–6G). No obvious gene expression
changes were detected in BAT and liver, except for an increase
in Adrb3 in BAT that did not lead to increased cAMP levels (Fig-
ures S6M and S6N). This complete lack of age-associated phe-
notypes and life span extension in aged line 1 BRASTO mice
shows a stark contrast to all significant phenotypes and life
span extension observed in line 10 BRASTO mice, providing
further strong support for our conclusion that the activation of
the DMH and LH, regulated by Sirt1/Ox2r signaling, is critical
to significantly delay the aging process and extend life span
in mice.
DISCUSSION
Whether Sirt1 regulates aging and longevity in mammals has
been a long-standing question in the field of sirtuin biology.
It has already been reported that whole-body overexpression-specific Sirt1, Nkx2-1, or Ox2r knockdown mice compared to control firefly
n values ± SE (*p < 0.05, **p < 0.01, ***p < 0.001 by Wilcoxon matched-pairs
rb2 in the soleus muscle from each knockdown mouse. Results are shown as
st, n = 4 mice for each group).
int are shown as mean values ± SE (***p < 0.001 by Wilcoxon matched-pairs
/LH-specific Sirt1 knockdown compared to fLuc knockdown in aged BRASTO
(OE) compared to control in aged B6mice (H and I). Results at each time point
us Tg-Sirt1 [F] or DMH-control versus DMH-Sirt1OE [H], *p < 0.05, ***p < 0.001
Tukey-Kramer post hoc test [G] and Student’s t test [I], n = 3–6 mice for each
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Figure 6. Another Line of BRASTOMice that ShowHigher Sirt1 Expression through theHypothalamus Exhibit theComplete Lack of Life Span
Extension, Beneficial Physiological Phenotypes, and Activation of the DMH and LH
(A) Levels of Sirt1 mRNA in the Arc, VMH, DMH, and LH of line 1 (left) and line 10 (right) BRASTO mice. Relative expression levels were calculated as the ratio of
Sirt1 mRNA in BRASTO mice versus wild-type control mice. (*p < 0.05, **p < 0.01 by one-way ANOVA with Tukey-Kramer post hoc test, n = 3 mice for each
genotype).
(B) mRNA expression levels of cFos in the Arc, VMH, DMH, and LH at 9 p.m. Results are shown asmean values ± SE (*p < 0.05 by Student’s t test, n = 4–6mice for
each genotype). mRNA expression levels in each hypothalamic nucleus were normalized to that in the WT Arc.
(C) Kaplan-Meier curves of line 1 BRASTO (Tg) and wild-type control (WT) mice in females (top left), males (top right), and combined sex (bottom left). p values
were calculated by log rank test.
(D) Identified causes of death in aged line 1 BRASTO and wild-type control mice.
(legend continued on next page)
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leading to the conclusion that Sirt1 might not be important
for the regulation of aging and longevity in mammals. The
recent controversy regarding the effect of Sir2 orthologs, sir-
2.1 and dSir2, on life span in worms and flies, respectively
(Burnett et al., 2011), has also fueled general doubts about
the role of Sir2 orthologs in aging/longevity control. On the
other hand, a recent study has demonstrated that whole-
body Sirt6-overexpressing transgenic mice show significant
life span extension, although it was observed only in males
(Kanfi et al., 2012).
Our present study has demonstrated that BRASTO mice,
particularly the ones in line 10 that display the DMH/LH-predom-
inant Sirt1 expression profile similar to that induced by DR, show
significant life span extension and delay in aging in both males
and females. Aged BRASTO mice displayed (1) significant delay
in age-associated mortality and cancer-dependent death inci-
dence; (2) significant enhancement in physical activity, body
temperature, oxygen consumption, and quality of sleep; (3)
more youthful structure and function in skeletal muscle; and (4)
enhanced neural activation and Ox2r expression specifically in
the DMH and LH. We have also identified Nkx2-1, a Nk2 family
homeobox transcription factor, as a new partner of Sirt1 in the
hypothalamus, and Sirt1 and Nkx2-1 cooperate to upregulate
Ox2r expression during the dark time. Importantly, results from
the DMH/LH-specific stereotactic experiments demonstrate
that Sirt1/Ox2r signaling in the DMH and LH is responsible to
counteract age-associated decline in those physiological func-
tions. Furthermore, comparison between two independent lines
of BRASTO mice reveals the tight association between the neu-
ral activation of the DMH and LH, delay in aging, and life span
extension in mice.
The DMH and LH Are the Critical Areas for the
Sirt1-Dependent Regulation of Aging and Longevity in
Mammals
Several lines of evidence strongly indicate that the DMH and LH
are the areas where Sirt1 regulates aging and longevity in mice.
First, all our results from stereotactic experiments in BRASTO
and wild-type mice clearly demonstrate the physiological
relevance and the importance of Sirt1/Nkx2-1/Ox2r-mediated
signaling in the DMH and LH for the regulation of physiological
functions associated with longevity. Second, BRASTO mice in
line 10 that show enhanced neural activation specifically in
the DMH and LH have significantly extended life span, whereas
BRASTO mice in line 1 that do not show life span extension
display no enhancement of neural activity in the DMH and
LH. Third, our previous study also demonstrates that Sirt1/
Ox2r signaling in the DMH and LH plays an important role for
the central adaptive response to DR. These findings suggest
that the DMH and LH function as a ‘‘control center’’ for
mammalian aging and longevity and that Sirt1/Nkx2-1/Ox2r-
mediated signaling in the DMH and LH plays a critical role for
maintaining youthful physiology and thereby mediating delay(E and F)Wheel-running activity (E) and rectal body temperature (F) at 20months o
Shaded area represents the dark time.
(G) mRNA expression levels of Pgc1a, Idh3a, and Adrb2 in the soleus muscle of ag
as mean values ± SE (n = 3 mice for each genotype). See also Figure S6.
Cell Mein aging and life span extension in mammals (Figure 7). This
Sirt1/Nkx2-1/Ox2r-mediated pathway likely controls the sensi-
tivity of a specific subset of DMH and LH neurons, namely
Sirt1/Nkx2-1 double-positive neurons, to orexin through the
regulation of Ox2r expression. Indeed, Sirt1 overexpression
was able to enhance the cFos response to orexin-B in primary
hypothalamic neurons (our preliminary finding). Currently, the
identity of these Sirt1/Nkx2-1 double-positive neurons is un-
known. It will be of great importance to precisely characterize
these Sirt1/Nkx2-1-double positive neurons, including the
neurotransmitter they use.
Potential Mechanisms by which Sirt1 in the DMH and
LH Counteracts Age-Associated Physiological Decline
and Thereby Contributes to Life Span Extension in
BRASTO Mice
How can Sirt1 in the DMH and LHmediate the effects of delaying
aging and extending life span? One possible explanation is that
Sirt1 mediates such beneficial effects by changing systemic
metabolic parameters. However, aged BRASTO mice did not
show any significant differences in metabolic phenotypes,
including body weight; fed and fasted glucose, insulin, and lipid
levels; and glucose and insulin tolerance. Keymetabolic genes in
WAT, BAT, and liver also showed no physiologically relevant
changes in aged BRASTO mice. Therefore, it seems unlikely
that Sirt1 mediates these beneficial effects by simply affecting
systemic metabolic profiles.
Interestingly, we found that skeletal muscle maintained youth-
ful structure and function in aged BRASTO mice. Because
hormones that can stimulate skeletal muscle, including cortico-
sterone, T3 and T4, and IGF-1, did not differ between aged
BRASTO and control mice, the hypothalamus-pituitary hormonal
axis does not seem to be responsible for these striking skeletal
muscle phenotypes in aged BRASTO mice. Instead, aged
BRASTO skeletal muscle showed significant increases in
Adrb2 expression and cAMP levels during the dark time, sug-
gesting that skeletal muscle is stimulated through the sympa-
thetic nervous system. The mechanism by which the signal
from the hypothalamus is specifically directed to skeletal muscle
still remains unknown. Nonetheless, skeletal muscle stimulated
by the sympathetic nervous system might induce systemic
events that contribute to the delay in aging and life span exten-
sion. Intriguingly, in flies, it has been reported that activating
FOXO signaling in muscle extends life span by enhancing
protein homeostasis in other tissues and inducing a systemic
fasting-like response (Demontis and Perrimon, 2010). Therefore,
in mammals, it is possible that skeletal muscle functions as a
downstream effector that regulates the systemic process of
aging in response to the neural signal coming from the hypothal-
amus. We are currently investigating this possibility in aged
BRASTO mice.
Another interesting possibility, which is not mutually exclu-
sive to other possibilities, is that maintaining higher delta
power in NREM sleep also contributes to delay in aging andf age. Results are shown asmean values ± SE (n = 6–8mice for each genotype).
ed line 1 BRASTOmice and wild-type control mice at 9 p.m. Results are shown
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Figure 7. A Model for the Role of Hypothalamic Sirt1 in the Regula-
tion of Aging and Longevity in Mammals
In the hypothalamus, specifically in the DMH and LH, Sirt1 upregulates Ox2r
expression and neural activation by interacting with and deacetylating Nkx2-1.
Enhanced neural activity in the DMH and LH stimulates the sympathetic ner-
vous system and maintains skeletal muscle mitochondrial morphology and
function, physical activity, body temperature, and oxygen consumption during
aging. This neural activation by Sirt1/Nkx2-1/Ox2r is also critical to preserve
quality of sleep during aging. These functional benefits contribute to the
maintenance of youthful physiology and promote longevity.
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NREM sleep, which diminishes with age in mice and humans
(Hasan et al., 2010; Landolt et al., 1996), is considered a mea-
sure of sleep intensity and a reflection of sleep quality (Krueger
et al., 2008). Our knockdown results show that the Sirt1/Nkx2-
1/Ox2r-mediated pathway is critical to maintain delta power in
NREM sleep. Because the functional connection between sleep
and aging/longevity control is poorly understood, this particular
finding provides an important clue to investigate the effect of
sleep intensity/quality on the aging process and life span in
mammals.
Implications from the Comparison of two Independent
BRASTO Lines for the Role of Hypothalamic Nuclei in
Aging/Longevity Control
A unique strength of our present study is that we were able to
conduct the comparison between two independent transgenic
lines that exhibited completely different aging/longevity pheno-
types. Because whole-genome analyses assured that there428 Cell Metabolism 18, 416–430, September 3, 2013 ª2013 Elseviewere no other systemically relevant genetic changes in these
two BRASTO lines, this striking phenotypic difference provides
an interesting opportunity to identify major determinants in the
Sirt1-dependent regulation of mammalian aging and longevity.
Given the importance of Sirt1 in the DMH and LH for the main-
tenance of youthful physiology, the key difference between lines
1 and 10 is probably not the difference in Sirt1 expression levels
in the DMH and LH but the difference in Sirt1 in other hypotha-
lamic nuclei, such as the Arc. Indeed, the Arc in line 1 BRASTO
mice exhibits much higher neural activity during the dark time
compared to controls, whereas there is no enhancement of neu-
ral activity in the DMH and LH. When the Arc is hyperactivated
due to relatively high Sirt1 activity, the neural activation in the
DMH and LH might be significantly suppressed, resulting in no
delay of aging and no life span extension. It has previously
been shown that there is a significant projection from the Arc
to the DMH and LH (Bouret et al., 2004), implying the possibility
that the Arc could regulate the neural activity of the DMH and LH.
It will be of great interest to compare DMH/LH-specific and Arc-
specific Sirt1 overexpressors for aging and longevity pheno-
types. Although further investigation will be required to test these
possibilities, our findings shed new light on potential regulatory
circuits within the hypothalamus that could modify the function
of the DMH and LH for the regulation of aging and longevity in
mammals.
CONCLUSION
Our present study demonstrates the importance of hypothalamic
Sirt1 in aging/longevity control in mice. The Sirt1/Nkx2-1/
Ox2r-mediated pathway in the DMH and LH stimulates skeletal
muscle function via the sympathetic nervous system and main-
tains youthful physiology, contributing to the delay in aging and
life span extension. These findings open a novel possibility
that intertissue communication between the hypothalamus
and peripheral tissues through the autonomic neural network
plays a critical role in the regulation of aging and longevity in
mammals.
EXPERIMENTAL PROCEDURES
Life Span Analysis
All animals were kept in our animal facility with free access to standard labo-
ratory diet and water. Repeated serological tests verified that the mice housed
in our suite were specific pathogen free. No mice used for the longevity study
were used for any other biochemical, physiological, ormetabolic tests. All mice
in the aging cohorts were carefully inspected every day. The endpoint of life
was the time when each mouse was found dead during daily inspection. Mori-
bund mice were euthanized according to our institutional animal care guide-
lines, and the time at euthanasia was its endpoint. Survival data of each cohort
were analyzed by plotting the Kaplan-Meier curve and performing the log rank
test using PASW Statistics Version 18.0 (IBM). In addition to median life span,
maximum 90% or 80% life span, the age at which 10% or 20% of the mice in
each cohort remain alive, respectively, were compared between BRASTO and
wild-type control mice for each sex using Student’s t test. Necropsy was con-
ducted immediately after death or euthanasia by the Washington University
Mouse Pathology Core facility. Age-associated mortality rate (qx) was esti-
mated as the number of animals alive at the end of the interval over the number
of animals at the start of the interval. The hazard rate (hz) was estimated by hz =
2qx/ (2-qx) (de Magalha˜es et al., 2005), and natural logarithm of hzwas plotted.
Difference between BRASTO and wild-type control mice was measured using
analysis of covariance (ANCOVA).r Inc.
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Assessments of both wheel-running and exploratory (vertical rearing) activities
over the 24 hr periods and measurements of rectal body temperature were
performed as previously described (Satoh et al., 2010). Metabolic parameters
were measured using an Oxymax indirect calorimetry system (Columbus
Instruments), as described previously (Yoshino et al., 2011). Details for sleep
analysis and stereotactic experiments are described in the Supplemental
Experimental Procedures. All animal studies were approved by the Washing-
ton University Animal Studies Committee and were in accordance with NIH
guidelines.
Statistical Analysis
Differences between two groups were assessed using the Student’s unpaired
t test. Comparisons among several groups were performed using one-way
ANOVA with the Tukey-Kramer post hoc test. Wilcoxon matched-pairs
singled-ranks test was used to compare differences in physical activity, meta-
bolic phenotypes, and delta power. p < 0.05 was considered statistically
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://dx.doi.org/10.1016/j.cmet.2013.07.013. The whole-genome
sequencing data for two BRASTO transgenic lines are available at the
following archive site: http://cgs.wustl.edu/solexa/Imai_0619/. To open the
files, a genome viewer such as the Integrative Genomics View (IGV; http://
www.broadinstitute.org/igv/) is required.
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